BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17987106)

  • 21. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.
    Martin N; Schwamborn K; Schreiber V; Werner A; Guillier C; Zhang XD; Bischof O; Seeler JS; Dejean A
    EMBO J; 2009 Nov; 28(22):3534-48. PubMed ID: 19779455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier.
    Wang J; Zhang H; Iyer D; Feng XH; Schwartz RJ
    J Biol Chem; 2008 Aug; 283(34):23235-43. PubMed ID: 18579533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.
    Chandhoke AS; Karve K; Dadakhujaev S; Netherton S; Deng L; Bonni S
    Cell Death Differ; 2016 May; 23(5):876-88. PubMed ID: 26679521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
    Chandhoke AS; Chanda A; Karve K; Deng L; Bonni S
    Oncotarget; 2017 Mar; 8(13):21001-21014. PubMed ID: 28423498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
    Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
    J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.
    Jiao J; Zhang R; Li Z; Yin Y; Fang X; Ding X; Cai Y; Yang S; Mu H; Zong D; Chen Y; Zhang Y; Zou J; Shao J; Huang Z
    Nat Commun; 2018 Jun; 9(1):2504. PubMed ID: 29950561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration.
    Wang L; Zhang J; Banerjee S; Barnes L; Sajja V; Liu Y; Guo B; Du Y; Agarwal MK; Wald DN; Wang Q; Yang J
    Oncotarget; 2010 Nov; 1(7):620-627. PubMed ID: 21317457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
    Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
    J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
    Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
    Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disrupting PIAS3-mediated SUMOylation of MLK3 ameliorates poststroke neuronal damage and deficits in cognitive and sensorimotor behaviors.
    Jiang Y; Hu L; Wang B; Zhang B; Shao M; Meng L; Xu Y; Chen R; Li M; Du C
    Cell Mol Life Sci; 2024 Mar; 81(1):119. PubMed ID: 38456949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
    Depaux A; Regnier-Ricard F; Germani A; Varin-Blank N
    Oncogene; 2007 Oct; 26(46):6665-76. PubMed ID: 17533377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.
    Albor A; Kulesz-Martin M
    Mol Carcinog; 2007 Aug; 46(8):585-90. PubMed ID: 17626251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The RanBP2/RanGAP1*SUMO1/Ubc9 complex: a multisubunit E3 ligase at the intersection of sumoylation and the RanGTPase cycle.
    Flotho A; Werner A
    Nucleus; 2012; 3(5):429-32. PubMed ID: 22925898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAB2, an important upstream adaptor of interleukin-1 signaling pathway, is subject to SUMOylation.
    Wang X; Jiang J; Lu Y; Shi G; Liu R; Cao Y
    Mol Cell Biochem; 2014 Jan; 385(1-2):69-77. PubMed ID: 24096733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sumoylation of a small isoform of NFATc1 is promoted by PIAS proteins and inhibits transactivation activity.
    Kim ET; Kwon KM; Lee MK; Park J; Ahn JH
    Biochem Biophys Res Commun; 2019 May; 513(1):172-178. PubMed ID: 30952432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-κB repression by PIAS3 mediated RelA SUMOylation.
    Liu Y; Bridges R; Wortham A; Kulesz-Martin M
    PLoS One; 2012; 7(5):e37636. PubMed ID: 22649547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-specific SUMOylation of viral polymerase processivity factor: a way of localizingtoND10 subnuclear domains for restricted and self-controlled reproduction of herpesvirus.
    Lai S; Xu M; Wang Y; Li R; Xia C; Xia S; Chen J
    Virulence; 2021 Dec; 12(1):2883-2901. PubMed ID: 34747321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.